<- Go Home
PanGenex Corporation
As of April 8, 2008, PanGenex Corporation was acquired by Calgenex Corporation, in a reverse merger transaction. PanGenex Corp. develops and markets nutraceuticals and topical over the counter (OTC) drugs and personal care products. Its products include Calci-CLEAR, a program that helps cleanse bodies of calcium crystals; Omeganol, a supplement that combines the triglyceride-lowering properties of omega 3s with the cholesterol balancing activity of tocotrienols; and Dermallve, a lotion that relieves symptoms of chronic skin diseases. The company caters to nutraceutical and cardiovascular health industries. PanGenex is based in Tampa, Florida.
Market Cap
$30.7M
Volume
4.00
Cash and Equivalents
$13.5K
EBITDA
-$1.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$78.3K
Profit Margin
9.40%
52 Week High
$8.3K
52 Week Low
$0.12
Dividend
N/A
Price / Book Value
-562.25
Price / Earnings
-566.74
Price / Tangible Book Value
-562.25
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$1.5M
Return on Equity
121.66%
Return on Assets
-76.02
Cash and Short Term Investments
$13.5K
Debt
$1.9M
Equity
-$2.1M
Revenue
$832.7K
Unlevered FCF
-$696.0K
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium